siRNA-mediated inhibition of endogenous brain-derived neurotrophic factor gene modulates the biological behavior of HeLa cells.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1316, doi. 10.3892/or.2021.7922
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2021 AND VI 45 AND IP 3
Results: 47
1
2
Exogenous hydrogen sulfide exerts proliferation, anti-apoptosis, migration effects and accelerates cell cycle progression in multiple myeloma cells via activating the Akt pathway.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1315, doi. 10.3892/or.2021.7923
- By:
- Publication type:
- Article
3
Repurposing of a monoamine oxidase A inhibitor-heptamethine carbocyanine dye conjugate for paclitaxel-resistant non-small cell lung cancer.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1306, doi. 10.3892/or.2021.7950
- By:
- Publication type:
- Article
4
Role of ERCC5 polymorphisms in non-small cell lung cancer risk and responsiveness/toxicity to cisplatin-based chemotherapy in the Chinese population.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1295, doi. 10.3892/or.2021.7935
- By:
- Publication type:
- Article
5
Acidic microenvironment induction of interleukin-8 expression and matrix metalloproteinase-2/-9 activation via acid-sensing ion channel 1 promotes breast cancer cell progression.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1284
- By:
- Publication type:
- Article
6
Expression of immune response biomarkers (PD-L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1273, doi. 10.3892/or.2021.7928
- By:
- Publication type:
- Article
7
DMAPT-D6 induces death-receptor-mediated apoptosis to inhibit glioblastoma cell oncogenesis via induction of DNA damage through accumulation of intracellular ROS.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1261, doi. 10.3892/or.2021.7932
- By:
- Publication type:
- Article
8
Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1249
- By:
- Publication type:
- Article
9
Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1235
- By:
- Publication type:
- Article
10
ESM1/HIF-1α pathway modulates chronic intermittent hypoxia-induced non-small-cell lung cancer proliferation, stemness and epithelial-mesenchymal transition.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1226
- By:
- Publication type:
- Article
11
DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1213, doi. 10.3892/or.2021.7951
- By:
- Publication type:
- Article
12
LINC00665 functions as a competitive endogenous RNA to regulate AGTR1 expression by sponging miR-34a-5p in glioma.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1202, doi. 10.3892/or.2021.7949
- By:
- Publication type:
- Article
13
Acanthopanax senticosus Harms extract causes G0/G1 cell cycle arrest and autophagy via inhibition of Rubicon in human liver cancer cells.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1193, doi. 10.3892/or.2021.7948
- By:
- Publication type:
- Article
14
High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1182, doi. 10.3892/or.2021.7940
- By:
- Publication type:
- Article
15
Critical immunosuppressive effect of MDSC-derived exosomes in the tumor microenvironment.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1171, doi. 10.3892/or.2021.7936
- By:
- Publication type:
- Article
16
JMJD2C triggers the growth of multiple myeloma cells via activation of β-catenin.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1162, doi. 10.3892/or.2021.7934
- By:
- Publication type:
- Article
17
Radiation exposure triggers the malignancy of non-small cell lung cancer cells through the activation of visfatin/Snail signaling.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1153, doi. 10.3892/or.2021.7929
- By:
- Publication type:
- Article
18
In vitro and ex vivo anti-tumor effect and mechanism of Tucatinib in leukemia stem cells and ABCG2-overexpressing leukemia cells.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1142
- By:
- Publication type:
- Article
19
Catechol enhances chemo- and radio-sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1133, doi. 10.3892/or.2021.7924
- By:
- Publication type:
- Article
20
lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR-18a-5p/SOX6 signaling axis.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1118, doi. 10.3892/or.2021.7931
- By:
- Publication type:
- Article
21
IL-6 plays a crucial role in epithelial-mesenchymal transition and pro-metastasis induced by sorafenib in liver cancer.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1105, doi. 10.3892/or.2021.7926
- By:
- Publication type:
- Article
22
Long non-coding RNA AFAP1-AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR-145/HOXA1 axis.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1094
- By:
- Publication type:
- Article
23
lncRNA HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10b.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1083
- By:
- Publication type:
- Article
24
Hsa_circ_0008537 facilitates liver carcinogenesis by upregulating MCL1 and Snail1 expression via miR-153-3p.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1072, doi. 10.3892/or.2021.7941
- By:
- Publication type:
- Article
25
Long non-coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO-mediated demethylation.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1059
- By:
- Publication type:
- Article
26
Nucleolar and spindle-associated protein 1 promotes non-small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1044
- By:
- Publication type:
- Article
27
Circadian clock protein CRY1 prevents paclitaxel-induced senescence of bladder cancer cells by promoting p53 degradation.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1033
- By:
- Publication type:
- Article
28
Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1023, doi. 10.3892/or.2021.7944
- By:
- Publication type:
- Article
29
Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 1011, doi. 10.3892/or.2021.7939
- By:
- Publication type:
- Article
30
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 997, doi. 10.3892/or.2021.7947
- By:
- Publication type:
- Article
31
Beclin1-armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R-CHOP against lymphoma in vitro and in vivo.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 987, doi. 10.3892/or.2021.7942
- By:
- Publication type:
- Article
32
VSP-17 suppresses the migration and invasion of triple-negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 975
- By:
- Publication type:
- Article
33
Use of miR-145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 963, doi. 10.3892/or.2021.7925
- By:
- Publication type:
- Article
34
Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell-based vaccines in murine colon carcinoma.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 945, doi. 10.3892/or.2021.7930
- By:
- Publication type:
- Article
35
MicroRNA-642a-5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 933
- By:
- Publication type:
- Article
36
CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 921, doi. 10.3892/or.2021.7920
- By:
- Publication type:
- Article
37
MicroRNA-34a-5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase-2 silencing.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 911
- By:
- Publication type:
- Article
38
HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 899
- By:
- Publication type:
- Article
39
Potentially life-threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 891
- By:
- Publication type:
- Article
40
Waterpipe smoke condensate influences epithelial to mesenchymal transition and interferes with the cytotoxic immune response in non-small cell lung cancer cell lines.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 879, doi. 10.3892/or.2021.7938
- By:
- Publication type:
- Article
41
Combination treatment with VPA and MSCs-TRAIL could increase anti-tumor effects against intracranial glioma.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 869, doi. 10.3892/or.2021.7937
- By:
- Publication type:
- Article
42
Identification of a PLCE1-regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinoma.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 857, doi. 10.3892/or.2021.7921
- By:
- Publication type:
- Article
43
Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 846, doi. 10.3892/or.2021.7946
- By:
- Publication type:
- Article
44
CD155/TIGIT, a novel immune checkpoint in human cancers.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 835, doi. 10.3892/or.2021.7943
- By:
- Publication type:
- Article
45
Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 824, doi. 10.3892/or.2021.7927
- By:
- Publication type:
- Article
46
Role of chemokines in hepatocellular carcinoma.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 809
- By:
- Publication type:
- Article
47
Endoplasmic reticulum stress, cell death and tumor: Association between endoplasmic reticulum stress and the apoptosis pathway in tumors.
- Published in:
- Oncology Reports, 2021, v. 45, n. 3, p. 801, doi. 10.3892/or.2021.7933
- By:
- Publication type:
- Article